Lv2
120 积分 2023-04-19 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
2小时前
待确认
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial
4小时前
已完结
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
4小时前
已完结
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes
4小时前
求助中
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
27天前
已完结
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome
1个月前
已完结
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
1个月前
已完结
The therapeutic age of the neonatal Fc receptor
2个月前
已完结
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
2个月前
已关闭
[Chinese expert consensus on the diagnosis and treatment of dry eye (2024)]
3个月前
已完结
皖公网安备34019202002308
